Ledger.Open graph →
SEC Form D · filed March 30, 2020

Medicenna Therapeutics Corp

Offering
$6.7M
Sold
$6.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
TORONTO, Ontario, Canada
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Elizabeth Williams · TORONTO, Ontario, CanadaExecKaren G. Dawes · TORONTO, Ontario, CanadaDirectorAlbert G. Beraldo · TORONTO, Ontario, CanadaDirectorAndrew G. Strong · TORONTO, Ontario, CanadaDirectorRosemina G. Merchant · TORONTO, Ontario, CanadaDirectorFahar Merchant · TORONTO, Ontario, CanadaExec · DirectorChandra Panchal · TORONTO, Ontario, CanadaDirectorMichael Mccartan · RIDGEFIELD, CTDirectorJames M. Flint · Centennial, CODirectorKumar E. Srinivasan · Houston, TXDirectorStephen L. Castree · Hamilton Parish, BermudaExec · DirectorGeoff M. Stephen · Centennial, CODirectorColin E. Broom · Houston, TXDirectorBarry Mccarthy · San Francisco, CAExecAlexander Kuppers · ANN ARBOR, MIDirectorGeorge L. Edwards · ANN ARBOR, MIDirectorScott L. Macdonald · ANN ARBOR, MIDirectorHelene Mayer · New York, NYExec · DirectorGotham Green GP Iii, LLC · SANTA MONICA, CADirectorAdam Wagner · San Diego, CADirectorJeffrey Shapiro · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗